These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 5993141)

  • 1. [Studies with Proresid (SP-I) in various transplantable tumors].
    Cerletti A; Stähelin H; Schoch J
    Med Klin; 1966 Jul; 61(30):1192-4. PubMed ID: 5993141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)].
    Bîrzu I
    Ther Umsch; 1966 Dec; 23(12):522-7. PubMed ID: 5980440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor-host relations in the comprehension of chemotherapeutic effects].
    Witte S; Goldenberg DM
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):517-22. PubMed ID: 4180646
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of Proresid on the growth and formation of metastases of the RBI-sarcoma in rats].
    Svec F; Altaner C
    Med Klin; 1968 Dec; 63(52):2119-25. PubMed ID: 5729222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of podophyllin acid ethyl hydrazide associated with x-rays on a solid isologous tumor in C3H mice].
    Donner M; Oth D; Burg C
    Rev Med Liege; 1968 Oct; ():Suppl 1:161-5. PubMed ID: 5712323
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
    Motti VJ
    Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental bases and clinical aspects of the use of 2 antimitotic derivatives of podophyllum].
    Fanchamps A
    J Med (Oporto); 1965 Nov; 58(191):673-92. PubMed ID: 5215285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
    Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y
    Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790
    [No Abstract]   [Full Text] [Related]  

  • 11. [5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)].
    Hubacher O
    Dtsch Med Wochenschr; 1965 Nov; 90(48):2145-9. PubMed ID: 5844793
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental studies with Proresid in inoculated sarcoma of the mouse].
    Hilscher W; Ritzl F; Stockhausen W; Witt I
    Strahlentherapie; 1970 Oct; 140(4):460-2. PubMed ID: 5510464
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
    Szántó L; Lörincz G; Gömör B
    Arzneimittelforschung; 1968 Jul; 18(7):886-9. PubMed ID: 5756046
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of juvenile papilloma of the larynx with resin of podophyllin.
    Fabritius HF
    Acta Otolaryngol; 1966 Jun; ():Suppl 224:467+. PubMed ID: 5992700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observations and results of the treatment of malignant tumors with podophyllim derivatives Sp-I and Sp-G].
    Tomov V; Popov G; Stoianov E
    Khirurgiia (Sofiia); 1965; 18(6):623-32. PubMed ID: 5886870
    [No Abstract]   [Full Text] [Related]  

  • 16. Podophyllin-salicylic acid solution in treatment of basal cell carcinomas.
    Nelson LM
    Arch Dermatol; 1966 Apr; 93(4):457-9. PubMed ID: 5862640
    [No Abstract]   [Full Text] [Related]  

  • 17. [New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo].
    Heckmann U
    Dtsch Med Wochenschr; 1967 May; 92(20):932-5 passim. PubMed ID: 4960735
    [No Abstract]   [Full Text] [Related]  

  • 18. SPI and SPG in the treatment of advanced malignant lesions.
    Grewal TS; Samual KC; Sachdev DL; Rastogi DC
    Int Surg; 1967 Oct; 48(4):360-7. PubMed ID: 6050546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apropos of a case of carcinoma of the ovary].
    Clerc JP
    Gynaecologia; 1968; 165(2):77-8. PubMed ID: 5703823
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems in combined radio-cytostatic therapy. 7. Syncarcinolytic studies using 5-fluorouracil, natulan and proresid in Crocker sarcoma 180 of mice].
    Ringleb D; Krieg R; Sauer D
    Strahlentherapie; 1969 Oct; 138(4):423-8. PubMed ID: 5352491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.